Revie 2018-12-07T14:43:05+00:00

Project Description

A novel drug for osteoporosis

Targeting a membrane receptor may result in potential therapeutic effects in several types of clinical conditions including osteoporosis.

Our researchers at NTNU have demonstrated novel inhibitors to efficiently and selectively inhibit signaling of this receptor in a model cell system. We put forward to optimize these novel drug leads into molecules that would be potential osteoporosis drugs for major pharma-companies.